Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-07 5:22 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,712,478 7.25% | 2,712,478 (New Position) | View |
2024-01-22 4:31 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | Artal International S.C.A. | 2,717,538 7.3% | 2,717,538 (New Position) | View |
2024-01-12 5:11 pm Purchase | 13D | SOLID BIOSCIENCES INC SLDB | PERCEPTIVE ADVISORS LLC | 6,925,028 18.6% | 3,423,763 (+97.79%) | View |
2024-01-12 5:05 pm Unchanged | 13D | SOLID BIOSCIENCES INC SLDB | BCLS SB Investco LP | 2,301,955 6.2% | 0 (Unchanged) | View |
2024-01-12 3:36 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | Flynn James E | 2,260,398 6.08% | 2,260,398 (New Position) | View |
2024-01-11 5:24 pm Purchase | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 4,348,828 11.7% | 917,210 (+26.73%) | View |
2024-01-10 4:31 pm Unchanged | 13D | SOLID BIOSCIENCES INC SLDB | BCLS SB Investco LP | 2,301,955 11.4% | 0 (Unchanged) | View |
2023-02-13 4:39 pm Sale | 13G | SOLID BIOSCIENCES INC SLDB | K2 PRINCIPAL FUND L.P. | 284,871 1.46% | -5,424,329 (-95.01%) | View |
2023-02-13 08:45 am Unchanged | 13G | SOLID BIOSCIENCES INC SLDB | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
2023-02-09 5:55 pm Sale | 13G | SOLID BIOSCIENCES INC SLDB | EcoR1 Capital LLC | 0 0% | -9,202,702 (Position Closed) | View |
2023-02-03 4:31 pm Unchanged | 13D | SOLID BIOSCIENCES INC SLDB | PERCEPTIVE ADVISORS LLC | 3,501,265 17.9% | 0 (Unchanged) | View |
2022-12-12 09:50 am Purchase | 13G | SOLID BIOSCIENCES INC SLDB | Camber Capital Management LP | 1,418,440 7.26% | 1,418,440 (New Position) | View |
2022-12-06 4:30 pm Sale | 13D | SOLID BIOSCIENCES INC SLDB | PERCEPTIVE ADVISORS LLC | 3,501,265 17.9% | -9,961,287 (-73.99%) | View |
2022-12-05 5:12 pm Sale | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 3,431,618 17.57% | -9,016,255 (-72.43%) | View |
2022-12-05 4:28 pm Sale | 13D | SOLID BIOSCIENCES INC SLDB | BCLS SB Investco LP | 2,301,955 11.8% | -5,627,963 (-70.97%) | View |
2022-10-04 5:14 pm Unchanged | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 12,447,873 11.01% | 0 (Unchanged) | View |
2022-10-03 5:11 pm Unchanged | 13D | SOLID BIOSCIENCES INC SLDB | BCLS SB Investco LP | 7,929,918 7% | 0 (Unchanged) | View |
2022-09-06 4:50 pm Purchase | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 12,447,873 11.01% | 80,000 (+0.65%) | View |
2022-09-02 4:50 pm Purchase | 13D | SOLID BIOSCIENCES INC SLDB | PERCEPTIVE ADVISORS LLC | 13,462,552 11.9% | 50,000 (+0.37%) | View |
2022-08-31 5:49 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | K2 PRINCIPAL FUND L.P. | 5,709,200 5.05% | 5,709,200 (New Position) | View |